BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jayasekera D, Hartmann P. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease. World J Hepatol 2023; 15(5): 609-640 [PMID: 37305367 DOI: 10.4254/wjh.v15.i5.609]
URL: https://www.wjgnet.com/1948-5182/full/v15/i5/609.htm
Number Citing Articles
1
Maria Oana Săsăran, Carmen Muntean, Ancuța Lupu, Vasile Valeriu Lupu. Neutrophils: tissue and circulating signatures of pediatric non-alcoholic fatty liver diseaseFrontiers in Cell and Developmental Biology 2024; 11 doi: 10.3389/fcell.2023.1336033
2
Sunitha Vimalesvaran, Pietro Vajro, Anil Dhawan. Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectivesHepatology International 2024; 18(S2): 873 doi: 10.1007/s12072-024-10691-5
3
Helaina E. Huneault, Jaclyn S. Lo, Shasha Bai, Zhulin He, Michael J. McPhaul, Fernando Bril, Miriam B. Vos, Melanie G. Cree. Fasting intact insulin by mass spectrometry is associated with metabolic dysfunction–associated steatotic liver disease in youthHepatology Communications 2024; 8(12) doi: 10.1097/HC9.0000000000000582
4
Greta Viebahn, Phillipp Hartmann, Sonja Lang, Münevver Demir, Xinlian Zhang, Derrick E. Fouts, Peter Stärkel, Bernd Schnabl. Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver diseaseGut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2307586
5
Claudia Mandato, Pietro Vajro. Serum alanine aminotransferase: Are we still far from a one‐size‐fits‐all pediatric reference cutoff strategy?Journal of Pediatric Gastroenterology and Nutrition 2024; 78(3): 453 doi: 10.1002/jpn3.12037